A groundbreaking study published in Frontiers in Public Health highlights the transformative role of artificial intelligence (AI) in improving infection prevention and control (IPC) measures in critical healthcare settings.
Royal Philips and Mayo Clinic today announced a research collaboration aimed at advancing MRI for cardiac applications.
This review article analyzes advancements in robotic surgery, highlighting new surgical platforms and their impact on clinical practices and patient outcomes.
HeartLung Technologies (www.heartlung.ai), a leading developer of innovative AI solutions for early detection of heart disease, lung cancer, and other fatal conditions is pleased to announce that four of its scientific research studies on AI-CAC™, AutoBMD™, and AI-CVD™ have been accepted for presentation at the 2014 Radiological Society of North America (RSNA).
UC San Diego researchers demonstrate GPT-4's capability in functional genomics, potentially transforming gene set analysis and precision medicine approaches.
Siemens Healthineers and DeepHealth, Inc., a global leader in AI-powered health informatics and a wholly-owned subsidiary of RadNet, Inc., today announced a strategic collaboration aimed at transforming ultrasound operations through the implementation of SmartTechnology™ by embedding AI-powered health informatics within workflows and imaging hardware.
Canon Medical Systems USA announces its expanded suite of AI-powered solutions for end-to-end workflow automation, featuring integrated tools that enhance Canon’s CT portfolio with remote scan support, Protocol Management, and automated processing of CT neuro and chest studies.
Serenus.AI is proud to introduce its latest suite of artificial intelligence solutions, designed to transform healthcare delivery by streamlining critical processes, ensuring timely, high-quality medical services for patients, and preventing delays in care across various medical fields.
Researchers from the University of Illinois Urbana-Champaign developed a small, four-fingered “hand” made from a single piece of DNA that can identify the COVID-19 virus with high sensitivity and speed and even prevent viral particles from infecting cells.
Profound Medical Corp., a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, is pleased to announce the unveiling of its third TULSA-AI software module, UA Alignment Assistant, in addition to six presentations featuring the Transurethral Ultrasound Ablation procedure, at the upcoming 110th Scientific Assembly and Annual Meeting of the Radiological Society of North America (“RSNA 2024”) being held in Chicago, IL, December 1-4, 2024, and the 25th Annual Meeting of the Society of Urologic Oncology (“SUO 2024”) taking place in Dallas, TX, December 4 - 6, 2024.
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.